| Virtual microdissection identifies distinct tumor-and stroma-specific subtypes of pancreatic ductal adenocarcinoma RA Moffitt, R Marayati, EL Flate, KE Volmar, SGH Loeza, KA Hoadley, ... Nature genetics 47 (10), 1168, 2015 | 2013 | 2015 |
| Long-term ERK inhibition in KRAS-mutant pancreatic cancer is associated with MYC degradation and senescence-like growth suppression TK Hayes, NF Neel, C Hu, P Gautam, M Chenard, B Long, M Aziz, ... Cancer cell 29 (1), 75-89, 2016 | 262 | 2016 |
| Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer M Anderson, R Marayati, R Moffitt, JJ Yeh Oncotarget 8 (34), 56081, 2017 | 182 | 2017 |
| Pentalogy of Cantrell AP Williams, R Marayati, EA Beierle Seminars in Pediatric Surgery 28 (2), 106-110, 2019 | 67 | 2019 |
| Metformin treatment does not inhibit growth of pancreatic cancer patient-derived xenografts MB Lipner, R Marayati, Y Deng, X Wang, L Raftery, BH O’Neil, JJ Yeh PloS one 11 (1), e0147113, 2016 | 44 | 2016 |
| Selective single cell isolation for genomics using microraft arrays JD Welch, LA Williams, M DiSalvo, AT Brandt, R Marayati, CE Sims, ... Nucleic Acids Research 44 (17), 8292-8301, 2016 | 30 | 2016 |
| EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth LV Bownes, AP Williams, R Marayati, LL Stafman, H Markert, CH Quinn, ... Plos one 16 (3), e0246244, 2021 | 27 | 2021 |
| Focal adhesion kinase inhibition contributes to tumor cell survival and motility in neuroblastoma patient-derived xenografts LL Stafman, AP Williams, R Marayati, JM Aye, HR Markert, EF Garner, ... Scientific Reports 9 (1), 13259, 2019 | 21 | 2019 |
| Immunotherapy in Pediatric Solid Tumors—A Systematic Review R Marayati, CH Quinn, EA Beierle Cancers 11 (12), 2022, 2019 | 20 | 2019 |
| PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells LL Stafman, AP Williams, R Marayati, JM Aye, JE Stewart, ... PloS one 14 (4), e0214469, 2019 | 15 | 2019 |
| Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma LV Bownes, R Marayati, CH Quinn, AM Beierle, SC Hutchins, JR Julson, ... Cancers 14 (8), 1952, 2022 | 14 | 2022 |
| CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells R Marayati, LL Stafman, AP Williams, LV Bownes, CH Quinn, HR Markert, ... Cancer Gene Therapy 29 (5), 558-572, 2022 | 13 | 2022 |
| Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy CH Quinn, AM Beierle, SC Hutchins, R Marayati, LV Bownes, JE Stewart, ... Cancers 14 (3), 762, 2022 | 11 | 2022 |
| PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma R Marayati, LL Stafman, AP Williams, LV Bownes, CH Quinn, JM Aye, ... Scientific Reports 11 (1), 5984, 2021 | 11 | 2021 |
| Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines LV Bownes, AP Williams, R Marayati, CH Quinn, SC Hutchins, JE Stewart, ... Cancers 13 (13), 3201, 2021 | 10 | 2021 |
| The Role of PIM Kinases in Pediatric Solid Tumors JR Julson, R Marayati, EA Beierle, LL Stafman Cancers 14 (15), 3565, 2022 | 7 | 2022 |
| Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like Tumor CH Quinn, AM Beierle, AP Williams, R Marayati, LV Bownes, HR Markert, ... Translational Oncology 14 (7), 101099, 2021 | 6 | 2021 |
| 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts R Marayati, LV Bownes, LL Stafman, AP Williams, CH Quinn, V Atigadda, ... Translational Oncology 14 (1), 100893, 2020 | 6 | 2020 |
| Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma R Marayati, AP Williams, LV Bownes, CH Quinn, JE Stewart, ... Journal of Pediatric Surgery, 2020 | 6 | 2020 |
| UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts AP Williams, EF Garner, LL Stafman, JM Aye, CH Quinn, R Marayati, ... Translational Oncology 12 (10), 1364-1374, 2019 | 6 | 2019 |
Jen Jen Yeh MDProfessor of Surgery and Pharmacology, University of North Carolina at Chapel HIllПотвърден имейл адрес: med.unc.edu
